Today, Gracie is back to 6th grade, back to roller-skating and back to learning new languages, all thanks to her dual heart-liver #transplant — a first for our team. Learn how we reached this milestone and how it has changed Gracie’s life. #DonateLifeMonth
At our Heart Institute, outcomes are more than just numbers. They represent children who have complex heart surgery and then go home to their families to grow up and live full lives.
See what our numbers say about our program and what they mean for the patients we treat.
https://bit.ly/4bIfRyn
A new Children’s Colorado study shows zorevunersen’s potential as a disease-modifying therapy for patients with #DravetSyndrome. Learn how this treatment works and what makes it different. #RareDisease
"Not all doctors are dentists but dentists are doctors. It's kind of like, all toads are frogs but not all frogs are toads."
– A patient we asked about National Doctors' Day
Happy Doctors' Day!
“I would like to devote more time to give back to the community that has given so much to me,” shares Dr. Kathleen Simpson. Starting this year, she’s doing just that by serving as a leader for the Pediatric Heart Transplant Society. #CardioSky #PedsCardio
Whole-genome sequencing is opening new doors to targeted therapy for rare diseases. Just ask Rowan's family. Because we understood the genetic cause of his tumor, we helped him avoid chemotherapy and amputation. #PrecisionMedicine
We are celebrating our next group of early-career investigators who received #research funding through our Colorado #ChildHealthResearch Institute. Read about their areas of focus — from heart disease to bone marrow transplants and more.
A CCTSI pilot grant helped David Howell, PhD, advance research on concussion‑related sleep and recovery in adolescents—leading to $4M in NIH funding and a first‑of‑its‑kind behavioral sleep intervention.
@childrensresearch.bsky.social, @cuanschutz.bsky.social, @cupediatrics.bsky.social
Why do some pediatric brain tumors come back after treatment?@cucancercenter.bsky.social researchers and pediatric oncologist Dr. Rajeev Vibhakar identified a new pathway behind therapy resistance that points to future treatment options. #OncSky #PediatricOncology
Read more: https://bit.ly/4u13K6O
Blue circular graphic highlighting a ranking. Large text reads "#1 In NIH pediatric research funding." Below, it states that the University of Colorado Anschutz School of Medicine's Department of Pediatrics is ranked No. 1 for 2025 NIH research funding, as per the Blue Ridge Institute for Medical Research. Logos for Children's Hospital Colorado and CU Anschutz are at the bottom.
We are proud to announce an exciting milestone for our NIH research funding! The @cupediatrics.bsky.social is ranked No. 1 in the Blue Ridge Institute for Medical Research rankings for top-funded medical school-based departments of pediatrics.
More on this achievement: https://bit.ly/4bjB4OP
A survey of academic #nephrology programs performed by our researchers found that young adults with #KidneyDisease lack structured support for successful transition from pediatric to adult nephrology care. #CKD #PediatricNephrology
750+ heart surgeries. 16 heart transplants. The No. 2 ranked pediatric cardiology team according to U.S. News & World Report. Numbers can tell you a lot about an organization, and our 2025 speaks volumes. #HeartMonth
With support from @americancancersoc.bsky.social, @cucancercenter.bsky.social researcher Dr. Amanda Winters is developing a better way to predict relapse in pediatric AML and bringing us closer to more targeted and timely treatments. #OncSky #CanSky
The number of children with heart disease is far less than adults, so why do children have much higher mortality rates? Our researchers explored this question and are determined to find answers.
#HeartMonth
Promotional poster for the PRISM conference and the providers at Children's Hospital Colorado, scheduled for January 29-31, 2026. Features images of youth athletes, statistics highlighting annual services, including 2.2 million youth athlete treatments, over 1,000 surgeries, and 500+ concussion treatments.
Image showing a schedule of speaker sessions including Erin M. Hayden, Rachel Meyers, Kelsie Richardson, Josh Kincaid, Catherine Donahue, and Sarah Petersen, detailing various topics related to athletic identity, treatment symptoms, and quality of life in adolescent athletes. Dates and times for each session are listed.
Hello from Austin and the 2026 @prismsociety.bsky.social Annual Meeting! We have 15 presenters including six podium talks focused on mental health, #concussions and injuries. We’re excited to share our research and learn from other teams.
Find the itinerary here: https://bit.ly/3Lt80dT
Our Neuro-Oncology Program has brought together experts in #NeuroOncology and autologous stem cell transplant to give families a consistent care team and improve outcomes. Learn more about our collaborative expertise. #PediatricBrainTumors
Portrait of a smiling person in a teal shirt, with a blurred indoor background.
Congratulations to Dr. Adam Green on a $99,975 grant from the DIPG Collaborative, funding research aimed at finding a cure for aggressive brain tumors. We are thankful to partner with The Cure Starts Now in support of driving this vital work forward. #CancerResearch
Our experts found that failure to account for bilateral conditions in clinical #OrthopedicResearch inflates false positives and may misinform care. See which analytical methods were most reliable.
A new study found similar complication rates between open and closed tibial #fractures, so what does this mean for surgery decisions and follow-up care? Our experts weigh in.
Our cardiac neurodevelopmental research team report in @jamapediatrics.com how they identified specific protein biomarkers that can help predict early language development outcomes in children with single ventricle heart disease. #SVHD #neurodevelopment #CardioSky
Gymnastics places unique demands on the body and requires equally unique care. Dr. Emily Sweeney and her colleagues are helping define gymnastics medicine as a subspecialty to better shape that care and help athletes thrive.
Dr. Dania Brigham says witnessing the resilience of children and the impact of liver transplants shaped her career. In this Q&A, she reflects on milestones like expanding our #LivingDonor liver program and coordinating a complex heart-liver transplant.
Meet Dr. Alisa Gaskell. She's been at the forefront of genetics research and recently led efforts to integrate #genetics and #PrecisionMedicine across our hospital. Learn more about what she sees as the exciting opportunities for the future.
Researchers at Children’s Colorado helped get the first drug approved to treat two rare kidney diseases. See the results of this breakthrough study. #research #ClinicalTrial #KidneyDisease
Our researchers are identifying ways to improve treatment delays in inflammatory bowel disease care. Learn more about the drivers behind these delays and how a group of doctors is trying to improve the process. #IBD #GISky
Our new Intestinal Rehab Simulation Center is preparing families for at-home parenteral nutrition. Discover how this is setting up families for success. #digestive #gastroenterology #PedsGI
With more focus on novel therapeutics and #PrecisionMedicine, the standard operating procedures developed decades ago are no longer adequate. Learn how our new ExACT Program is standing up the infrastructure needed to ensure patient safety well into the future.
We're excited to see our colleagues at the upcoming @ash.hematology.org annual conference Dec. 6 to 9 in Orlando. Don't miss presenters from Children's Colorado! Check out the schedule: https://www.hematology.org/meetings/annual-meeting #ASH2025
Portrait of a smiling person with short hair and glasses, wearing a beige top, against a light blue background.
Dr. Kathleen Simpson was recently selected as the Pediatric Heart Transplant Society Vice President Elect for 2025-2027. Dr. Simpson is a leader in pediatric heart transplantation, committed to advancing patient care and research. Congratulations, Dr. Simpson!
New #research from the PROMISE study shows the impact of elexacaftor/tezacaftor/ivacaftor (ETI) on inflammation and why that's a game changer for people with #CysticFibrosis. Read more about these promising results in collaboration with @cctsi.bsky.social. #PulmSky